These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 26214576)

  • 1. Introduction of Peripheral Carboxylates to Decrease the Charge on Tm(3+) DOTAM-Alkyl Complexes: Implications for Detection Sensitivity and in Vivo Toxicity of PARACEST MRI Contrast Agents.
    Suchý M; Milne M; Elmehriki AA; McVicar N; Li AX; Bartha R; Hudson RH
    J Med Chem; 2015 Aug; 58(16):6516-32. PubMed ID: 26214576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo detection of MRI-PARACEST agents in mouse brain tumors at 9.4 T.
    Li AX; Suchy M; Li C; Gati JS; Meakin S; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2011 Jul; 66(1):67-72. PubMed ID: 21254213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analogs of Eu3+ DOTAM-Gly-Phe-OH and Tm3+ DOTAM-Gly-Lys-OH: synthesis and magnetic properties of potential PARACEST MRI contrast agents.
    Suchý M; Li AX; Bartha R; Hudson RH
    Bioorg Med Chem; 2008 Jun; 16(11):6156-66. PubMed ID: 18457955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ParaCEST MRI contrast agents capable of derivatization via"click" chemistry.
    Milne M; Chicas K; Li A; Bartha R; Hudson RH
    Org Biomol Chem; 2012 Jan; 10(2):287-92. PubMed ID: 22069041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The thulium complex of 1,4,7,10-tetrakis{[N-(1H-imidazol-2-yl)carbamoyl]methyl}-1,4,7,10-tetraazacyclododecane (dotami) as a ParaCEST contrast agent.
    Burdinski D; Lub J; Pikkemaat JA; Langereis S; Grüll H; Ten Hoeve W
    Chem Biodivers; 2008 Aug; 5(8):1505-1512. PubMed ID: 18729087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly shifted LIPOCEST agents based on the encapsulation of neutral polynuclear paramagnetic shift reagents.
    Terreno E; Barge A; Beltrami L; Cravotto G; Castelli DD; Fedeli F; Jebasingh B; Aime S
    Chem Commun (Camb); 2008 Feb; (5):600-2. PubMed ID: 18209802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic PARACEST contrast agents for magnetic resonance imaging.
    Pikkemaat JA; Wegh RT; Lamerichs R; van de Molengraaf RA; Langereis S; Burdinski D; Raymond AY; Janssen HM; de Waal BF; Willard NP; Meijer EW; Grüll H
    Contrast Media Mol Imaging; 2007; 2(5):229-39. PubMed ID: 17937448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four-pool modeling of proton exchange processes in biological systems in the presence of MRI-paramagnetic chemical exchange saturation transfer (PARACEST) agents.
    Li AX; Hudson RH; Barrett JW; Jones CK; Pasternak SH; Bartha R
    Magn Reson Med; 2008 Nov; 60(5):1197-206. PubMed ID: 18958857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous in vivo pH and temperature mapping using a PARACEST-MRI contrast agent.
    McVicar N; Li AX; Suchý M; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2013 Oct; 70(4):1016-25. PubMed ID: 23165779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synthesis and screening of nonionic gadolinium (III) DTPA-bisamide complexes as magnetic resonance imaging contrast agents.
    Periasamy M; White D; deLearie L; Moore D; Wallace R; Lin W; Dunn J; Hirth W; Cacheris W; Pilcher G
    Invest Radiol; 1991 Nov; 26 Suppl 1():S217-20; discussion S232-5. PubMed ID: 1667003
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
    Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
    J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A DOTAM-based paraCEST agent favoring TSAP geometry for enhanced amide proton chemical shift dispersion and temperature sensitivity.
    Stevens TK; Milne M; Elmehriki AA; Suchý M; Bartha R; Hudson RH
    Contrast Media Mol Imaging; 2013; 8(3):289-92. PubMed ID: 23606433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete on/off responsive ParaCEST MRI contrast agents for copper and zinc.
    Srivastava K; Ferrauto G; Harris SM; Longo DL; Botta M; Aime S; Pierre VC
    Dalton Trans; 2018 Aug; 47(33):11346-11357. PubMed ID: 29897367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo detection of PARACEST agents with relaxation correction.
    Jones CK; Li AX; Suchý M; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2010 May; 63(5):1184-92. PubMed ID: 20432289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lanthanide(III) complexes that contain a self-immolative arm: potential enzyme responsive contrast agents for magnetic resonance imaging.
    Chauvin T; Torres S; Rosseto R; Kotek J; Badet B; Durand P; Tóth E
    Chemistry; 2012 Jan; 18(5):1408-18. PubMed ID: 22213022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
    Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
    Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triethylenetetramine penta- and hexa-acetamide ligands and their ytterbium complexes as paraCEST contrast agents for MRI.
    Burdinski D; Lub J; Pikkemaat JA; Moreno Jalón D; Martial S; Del Pozo Ochoa C
    Dalton Trans; 2008 Aug; (31):4138-51. PubMed ID: 18688432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes.
    Hermann P; Kotek J; Kubícek V; Lukes I
    Dalton Trans; 2008 Jun; (23):3027-47. PubMed ID: 18521444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized MRI contrast for on-resonance proton exchange processes of PARACEST agents in biological systems.
    Li AX; Suchy M; Jones CK; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2009 Nov; 62(5):1282-91. PubMed ID: 19780147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxylate ligands drastically enhance the rates of oxo exchange and hydrogen peroxide disproportionation by oxo manganese compounds of potential biological significance.
    Dubois L; Pécaut J; Charlot MF; Baffert C; Collomb MN; Deronzier A; Latour JM
    Chemistry; 2008; 14(10):3013-25. PubMed ID: 18293345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.